Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indobufen for thrombosis prevention in nephrotic syndrome
ChiCTR-IPR-17013428Phase 4Recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Sep 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Indobufen and warfarin in nephrosis (3 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoints: D-dimer, Color Doppler ultrasound of lower extremities and kidneys and 1 more. Started Sep 2017; status: recruiting.
02
Drugs
Indobufenwarfarin
03
Conditions
nephrosis
Beyond the preview
Go deeper on ChiCTR-IPR-17013428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013428.